Gabapentin Tablet, Film Coated
Product Images NDC 80425-0097

10 FDA label images from Advanced Rx Of Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 80425-0097). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Formula)

Formula (Formula)
An equation illustrating the calculation of creatinine clearance (CLCr) based on age, weight, serum creatinine, and an adjustment factor for female patients. This formula is used to estimate kidney function.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of gabapentin showing a cyclohexane ring with amino and carboxymethyl substituents.*
FDA Label Image

Fig_1 (Fig 1)

Fig_1 (Fig 1)
This line graph depicts weekly mean pain scores over an 8-week period in a study population. It compares a placebo group versus a Gabapentin 3600 mg/day group during a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10, and the x-axis shows weeks from baseline to week 8.*
FDA Label Image

Fig_2 (Fig 2)

Fig_2 (Fig 2)
A line graph depicting weekly mean pain scores over seven weeks in a clinical study population. The graph compares three groups: placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day. It shows a 3-week dose titration period followed by a 4-week fixed dose period, illustrating changes in mean pain scores from baseline through week 7.*
FDA Label Image

Fig_3 (Fig 3)

Fig_3 (Fig 3)
A bar chart titled 'Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies.' It compares response rates between placebo (PBO) and gabapentin (GBP) at different dosages (3600 mg, 1800 mg, and 2400 mg) across two studies, showing higher responder proportions in gabapentin groups with statistical significance indicated.*
FDA Label Image

Fig_4 (Fig 4)

Fig_4 (Fig 4)
A scatter plot graph titled 'Responder Rate in Patients Receiving Gabapentin Expressed as Difference from Placebo by Dose and Study' showing data points for three studies (a, b, c). The x-axis represents daily dose in mg (600 to 1800 mg), and the y-axis shows the difference in responder rate (%) from placebo. The chart compares the effect of gabapentin doses on patients aged 12 years and older with partial seizures across different studies.*
FDA Label Image

Label 1 (Lable 1)

Label 1 (Lable 1)
Gabapentin 600 mg oral film-coated tablets label from Advanced Rx of Tennessee, LLC. The label includes storage instructions (20-25°C), prescription drug status, lot number 30GAB600524, expiration date 5/31/2024, barcode, and comparison to Neurontin product with NDC 80425-0097-01.*
FDA Label Image

Label 2 (Lable 2)

Label 2 (Lable 2)
Gabapentin 600 mg film-coated tablet label from Advanced Rx of Tennessee, LLC. The label includes storage instructions at 20°-25°C, barcode, lot number G600623, expiration date 6/30/2023, and comparison to Neurontin. It also displays an NDC 80425-0097-02 and manufacturer Aurobindo Pharm serial number.*
FDA Label Image

Lab 3 (Label 3)

Lab 3 (Label 3)
Label for Gabapentin 600 mg film-coated tablets by Advanced Rx of Tennessee, LLC, Nashville. Includes storage instructions (20-25°C), federal transfer caution, barcode, lot number 90GAB600524, and expiration date 5/31/2024. Also references Aurobindo Pharma and compares to Neurontin with related NDC numbers.*
FDA Label Image

Lab 4 (Label 4)

Lab 4 (Label 4)
Gabapentin 600 mg film coated tablet label by Advanced Rx of Tennessee, LLC. The label includes storage instructions at 20°-25°C (68°-77°F), a comparison to Neurontin, and batch information. It also references the NDC 80425-0097 and an expiration date of 6/30/2023 from Aurobindo Pharma.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.